Cargando…
Preleukemia and Leukemia-Initiating Cell Activity in inv(16) Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is a collection of hematologic malignancies with specific driver mutations that direct the pathology of the disease. The understanding of the origin and function of these mutations at early stages of transformation is critical to understand the etiology of the disease an...
Autores principales: | Pulikkan, John Anto, Castilla, Lucio Hernán |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5932169/ https://www.ncbi.nlm.nih.gov/pubmed/29755956 http://dx.doi.org/10.3389/fonc.2018.00129 |
Ejemplares similares
-
Faggot cells in therapy‐related acute myeloid leukemia with inv(16)
por: Vega González de Viñaspre, Ana, et al.
Publicado: (2020) -
Genome-wide binding of transcription factors in inv(16) acute myeloid leukemia
por: Mandoli, A., et al.
Publicado: (2014) -
The assembly competence domain is essential for inv(16)-associated acute myeloid leukemia
por: Kim, Hyung-Gyoon, et al.
Publicado: (2017) -
Targeting miR-126 in inv(16) acute myeloid leukemia inhibits leukemia development and leukemia stem cell maintenance
por: Zhang, Lianjun, et al.
Publicado: (2021) -
Inv(3) Acute Myeloid Leukemia in a Young Adult and Review of the Literature
por: Blakemore, Carlee, et al.
Publicado: (2023)